Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-06

Clinical Trial Update: Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sequential therapy with Mexidol for chronic cerebral ischemia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mexidol (emoxypine)

Snippet

Sponsor: Pharmasoft | Conditions: Chronic Cerebral Ischemia | Phase 3 | Status: COMPLETED | Results posted: 2025-10-06